-
June 18, 2013
DaVita HealthCare entered into a strategic liaison with Myriad Genetics.
-
June 17, 2013
Recently, Medtronic won a patent infringement case over its peer Edwards LifeSciences.
-
June 17, 2013
Supreme Court reveals decision on Myriad's patent claims.
-
June 14, 2013
Life Technologies recently acquired a South Korea-based distributor, Life Science Korea.
-
June 11, 2013
Seattle Genetics commenced a phase I/II study to evaluate Adcetris in combination with Teva Pharma's Treanda ...
-
June 11, 2013
Life introduces its Oncomine Next Gen Sequencing Power Tools.
-
June 10, 2013
Quest Diagnostics reaffirms outlook for 2013, discusses current environment for growth.
-
June 10, 2013
We downgrade our recommendation on Edwards to Underperform.
-
February 08, 2013
Myriad Genetics Inc. (MYGN) reported EPS of 42 cents in the second quarter of fiscal 2013, representing a beat of ...
-
January 30, 2013
Qiagen NV (QGEN) reported earnings per share (EPS) of 16 cents in the fourth quarter of 2012, significantly up from ...
-
January 18, 2013
Qiagen NV (QGEN), a key provider of innovative technologies and products for pre-analytical sample preparation and ...
-
January 15, 2013
Qiagen (QGEN), a major provider of innovative technologies and products for pre-analytical sample preparation and ...
-
January 03, 2013
This morning, the market has been relatively quiet. The Nasdaq remains relatively unchanged; the S&P 500 is ...
-
January 02, 2013
Rising earnings estimates on the back of strong third quarter results - including a 28.2% earnings surprise - helped ...
-
December 27, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq is down 0.7%; the S&P 500 is trading down ...
-
December 21, 2012
Following a strong first quarter result and an encouraging guidance, we upgrade our recommendation on Myriad ...
-
December 19, 2012
Myriad Genetics (MYGN) has watched all 13 estimates for fiscal 2013 move higher in the last 60 days, following a ...
-
December 13, 2012
Genomic Health (GHDX), an oncology based biotech company, presented the results from 6 studies of the Oncotype DX ...
-
December 11, 2012
Myriad RBM, a wholly-owned subsidiary of molecular diagnostic company Myriad Genetics Inc. (MYGN), has recently ...
-
December 03, 2012
After the morning's trading, the Nasdaq is up 0.2%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2%. ...
